Search Results for "Treatment Of Neurofibroma In India"

05:27 EDT 19th August 2017 | BioPortfolio

Matching Channels

India ink colloidal carbon stain


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to:    

Specific treatment

Hormonal treatment

Matching News

NeurofibromaPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, NeurofibromaPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Neurofibroma. The DelveInsight'sReport covers...

UACT and others act to stop Xtandi patent in India

India’s Union for Affordable Cancer Treatment (UACT), along with 56 other organizations, has requested…

J&J, India's IMTECH collaborate on tuberculosis treatment R&D

Johnson & Johnson and India's Institute of Microbial Technology, part of the Council of Scientific and Industrial Research, w -More- 

Mylan HIV drug to be sold in India

Mylan's antiretroviral drug Avonza for first-line treatment of HIV/AIDS gained approval for release in India.  -More- 

500kg Egyptian sheds half her weight after India surgery

The "world's heaviest woman" has shed half her weight—around a quarter of a tonne—in the two months she's been in India for treatment, doctors said.

An overview of preventive healthcare in India

Healthcare in India is largely perceived as a science of treatment and blissfully ignores it as a science of prevention.

Doctors in India meet to condemn practice of paying referral kickbacks to GPs

Doctors in India have publicly condemned the payment of commissions to fellow doctors who refer patients to them for diagnosis, treatment, or surgery, and are seeking government intervention to curb.....

Top 10 Pharmaceutical Companies in India By BizVibe

Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances. With pharmaceutical research in India on the rise and advances in health, medical, and biotechnolo...

Matching PubMed Articles

An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.

Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targeted interventions may have therapeutic potent...

Successful treatment by negative-pressure wound therapy for ulcer located on diffuse plexiform neurofibroma.

Removal of solitary neurofibroma of the external nose by intranasal approach.

Solitary neurofibroma originating from the external nose is extremely rare, and to our knowledge, only 3 cases have been reported so far in English literatures. It may originate from the ophthalmic (V...

Treatment-seeking and out-of-pocket expenditure on childhood illness in a migrant tribal community in Bhubaneswar, Odisha State, India.

In India, migrant status, tribal affiliation and poverty render tribal migrants more vulnerable than any other group which leads to high treatment costs and the risk of low access to health care.

Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.

Bedaquiline (BDQ) has been approved in India for the treatment of multidrug-resistant tuberculosis (MDR-TB), but is currently recommended for MDR-TB patients who have failed initial treatment with sta...

Search Whole site using Google

Quick Search
Advertisement Advertisement